EIGR
Eiger BioPharmaceuticals Inc
Price:
8.5
USD
Volume:
137,824
United States | Biotechnology
EIGR Current Ratio
As of 2025-05-24, the Current Ratio of Eiger BioPharmaceuticals Inc (EIGR) is 0.71.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
EIGR Current Ratio - Historical Value
| Date | Value |
|---|---|
| 2022-12-31 | 0.71 |
| 2021-12-31 | 3.46 |
| 2020-12-31 | 8.3 |
| 2019-12-31 | 5.94 |
| 2018-12-31 | 10.18 |
| 2017-12-31 | 5.82 |
| 2016-12-31 | 11.42 |
| 2015-12-31 | 0.65 |
| 2014-12-31 | 13.35 |
| 2013-12-31 | 2.82 |
EIGR Current Ratio - Peers Comparison